TrialTheranostics2017

Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC.

Tao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.